Pathogenetic Basis of Aortopathy and Aortic Valve Disease

B
Benjamin Landis, MD

Primary Investigator

Overview

The purpose of this study is to identify genes related to aortopathy and aortic valve disease in order to determine the risk and severity of aortic disease in individuals starting at an early age or stage of disease.

Description

The purpose of this study is to obtain information from individuals and their families in order to define the complex genetic and pathogenic basis of thoracic aortic aneurysm and other forms of aortopathy and aortic valve disease by identifying new disease-causing genes and by identifying important genetic modifiers for aortic/aortic valve disease severity.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    aortopathy,aortic valve disease
  • Age: - 100 Years
  • Gender: All

Inclusion Criteria
Subjects with aortic disease including TAA* or dissection, aortic tortuosity, or aortic hypoplasia/stenosis (based on any cardiac imaging modality including echocardiography, CT, MRI, or angiography)
Subjects with a syndromic or genetic diagnosis that poses risk for the development of aortic disease who have not yet developed disease
Subjects with aortic valve disease
Family members of eligible subjects
Control subjects having tissue removed during a surgical procedure
Tissue donors who have authorized the use of their specimens for research
Leftover specimens being stored within an Indiana University and/or Indiana University Health lab or storage facility from patients who fall into previously described inclusion criteria
Exclusion Criteria
Inability or unwillingness to provide consent


Additional Information:
Participants may be compensated for their participation.

Updated on 09 Mar 2024. Study ID: 1509977311

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center